Perrigo Sued Over Infant Formula Disclosures as Lead-Plaintiff Deadline Nears

The filing targets Perrigo’s handling of a Nestlé formula acquisition, with later disclosures cited as catalysts for steep share declines.

Overview

A new securities class action, French v. Perrigo Company plc (S.D.N.Y.), seeks to represent investors who bought PRGO shares from February 27, 2023 through November 4, 2025.
Plaintiffs allege Perrigo misled investors about the Nestlé-acquired infant formula business, citing underinvestment, manufacturing deficiencies, and remediation costs that exceeded earlier estimates.
Robbins Geller, Pomerantz, Bernstein Liebhard, and Holzer & Holzer are soliciting class members, noting a January 16, 2026 deadline to seek appointment as lead plaintiff.
The complaint links stock drops to company updates on February 27, 2024 (extra $35–$45 million remediation and roughly 50% EPS decline, shares -15%), May 7, 2024 (-9.8%), and August 6, 2025 (production variability and higher scrap, shares -11%).
On November 5, 2025, Perrigo announced a strategic review of the formula unit, a reassessment of a $240 million investment, and lower fiscal 2025 guidance, followed by a roughly 25% share decline.